Ajanta Pharma Limited disclosed revised details regarding encumbrance of shares under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The revision, prompted by a discrepancy noted by the BSE, specifies the names of both the lender and the trustee who may hold shares directly or on behalf of the lender, concerning shares encumbered by Aayush Agrawal Trust. Entities including Gabs Investments Pvt Ltd, Yogesh Agrawal Trust, Rajesh Agrawal Trust, Ravi Agrawal Trust, and Ganga Exports have also created encumbrances on shares of Ajanta Pharma Limited.